-
Catalent, Ennaid Therapeutics collaborate to develop antiviral treatment for Covid-19 disease
pharmaceutical-business-review
May 18, 2020
Catalent has collaborated with speciality pharmaceutical company Ennaid Therapeutics for the development of an oral and antiviral treatment for Covid-19 disease.
-
Vyriad to Develop Antibody Test to Determine COVID-19 Protective Immunity
americanpharmaceuticalreview
May 18, 2020
Vyriad has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19.
-
App to help enrol COVID-19 patients into clinical trials developed
europeanpharmaceuticalreview
May 18, 2020
A new software has been developed, made to help find and enrol COVID-19 positive patients to accelerate clinical trials for new drugs and vaccines.
-
Spartan’s COVID-19 test recall exposes issues of rapid medical device approval, says report
europeanpharmaceuticalreview
May 18, 2020
Following the recall of Spartan Bioscience’s COVID-19 test by Health Canada, a report suggests this demonstrates the challenges associated with rapid approval.
-
Tech Mahindra leverages AI to research on potential therapeutic drugs for COVID-19
expresspharma
May 18, 2020
The company has conducted molecular docking studies of 19 FDA (Food and Drug Administration) approved ligands and anti-viral drugs.
-
COVID-19 clinical trials exhibit encouraging results: GlobalData
expresspharma
May 18, 2020
Four multinational clinical trials that are planning to enrol the most subjects are investigating remdesivir, sarilumab and bevacizumab.
-
PMC to dispense homoeopathy medicine in COVID-19 hotspots
expresspharma
May 18, 2020
The Pune Municipal Corporation (PMC) has decided to distribute a homoeopathic medicine, recommended by the AYUSH Ministry in the fight against coronavirus, to 70,000 households in the COVID-19 hotspot areas in the city, an official said on Friday.
-
AIIMS Bhopal claims good results in drug trial for COVID-19 treatment
expresspharma
May 18, 2020
Mycobacterium W was used for the treatment of leprosy and CSIR has tied up with Cadila Pharmaceuticals to evaluate its effect in hospitalised COVID-19 patients.
-
COVID-19 continues to disrupt clinical trials
expresspharma
May 18, 2020
69.9 per cent of disruptions due to the suspension of enrolment, informs a GlobalData study.
-
Bangladeshi doctors claim to have found drug combination to cure COVID-19 patients
expresspharma
May 18, 2020
Reportedly, the medical team is preparing a paper on the development of the drug combination for an international journal, as required for scientific review and acknowledgement.